Hansoh Pharma Publishes 2026 Interim Report; Shareholders Urged to Use Digital Access, Free Print Copies on Request

Bulletin Express09-23 17:44

Hansoh Pharmaceutical Group Company Limited (Hansoh Pharma) announced on 23 September 2026 that its Interim Report 2026 is now available in both English and Chinese on the company’s website (www.hspharm.com) and on the Hong Kong Stock Exchange’s HKEXnews portal (www.hkexnews.hk).

The board encourages shareholders and the investing public to review the online version to expedite access and support paper-saving efforts. Non-registered shareholders who cannot receive email notifications or access the web version may request a free printed copy. To obtain hard-copy materials, they must complete the enclosed request form and return it to the company’s Hong Kong branch share registrar, Tricor Investor Services Limited, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, using the prepaid mailing label, or email the registrar at 3692-ecom@vistra.com.

Shareholders holding shares through banks, brokers, custodians, nominees or HKSCC Nominees Limited are advised to provide a functional email address to their intermediaries to receive future electronic notices and actionable corporate communications. Until a valid email address is lodged with Tricor, such investors will receive printed notices and documents only.

Enquiries can be directed to Tricor’s hotline on +852 2980 1333 between 9:00 a.m. and 6:00 p.m., Monday to Friday (excluding public holidays), or via the above email. The notification letter is signed by Chairlady Zhong Huijuan on behalf of Hansoh Pharma.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1161478088?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-23 17:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1161478088","market":"hk","top_or_hot":-1,"title":"Hansoh Pharma Publishes 2026 Interim Report; Shareholders Urged to Use Digital Access, Free Print Copies on Request","media":"Bulletin Express","content":"<p>Hansoh Pharmaceutical Group Company Limited (Hansoh Pharma) announced on 23 September 2026 that its Interim Report 2026 is now available in both English and Chinese on the company’s website (www.hspharm.com) and on the Hong Kong Stock Exchange’s HKEXnews portal (www.hkexnews.hk).</p>\n<p>The board encourages shareholders and the investing public to review the online version to expedite access and support paper-saving efforts. Non-registered shareholders who cannot receive email notifications or access the web version may request a free printed copy. To obtain hard-copy materials, they must complete the enclosed request form and return it to the company’s Hong Kong branch share registrar, Tricor Investor Services Limited, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, using the prepaid mailing label, or email the registrar at 3692-ecom@vistra.com.</p>\n<p>Shareholders holding shares through banks, brokers, custodians, nominees or HKSCC Nominees Limited are advised to provide a functional email address to their intermediaries to receive future electronic notices and actionable corporate communications. Until a valid email address is lodged with Tricor, such investors will receive printed notices and documents only.</p>\n<p>Enquiries can be directed to Tricor’s hotline on +852 2980 1333 between 9:00 a.m. and 6:00 p.m., Monday to Friday (excluding public holidays), or via the above email. The notification letter is signed by Chairlady Zhong Huijuan on behalf of Hansoh Pharma.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hansoh Pharma Publishes 2026 Interim Report; Shareholders Urged to Use Digital Access, Free Print Copies on Request</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHansoh Pharma Publishes 2026 Interim Report; Shareholders Urged to Use Digital Access, Free Print Copies on Request\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-09-23 17:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hansoh Pharmaceutical Group Company Limited (Hansoh Pharma) announced on 23 September 2026 that its Interim Report 2026 is now available in both English and Chinese on the company’s website (www.hspharm.com) and on the Hong Kong Stock Exchange’s HKEXnews portal (www.hkexnews.hk).</p>\n<p>The board encourages shareholders and the investing public to review the online version to expedite access and support paper-saving efforts. Non-registered shareholders who cannot receive email notifications or access the web version may request a free printed copy. To obtain hard-copy materials, they must complete the enclosed request form and return it to the company’s Hong Kong branch share registrar, Tricor Investor Services Limited, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, using the prepaid mailing label, or email the registrar at 3692-ecom@vistra.com.</p>\n<p>Shareholders holding shares through banks, brokers, custodians, nominees or HKSCC Nominees Limited are advised to provide a functional email address to their intermediaries to receive future electronic notices and actionable corporate communications. Until a valid email address is lodged with Tricor, such investors will receive printed notices and documents only.</p>\n<p>Enquiries can be directed to Tricor’s hotline on +852 2980 1333 between 9:00 a.m. and 6:00 p.m., Monday to Friday (excluding public holidays), or via the above email. The notification letter is signed by Chairlady Zhong Huijuan on behalf of Hansoh Pharma.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03692","symbol_name":"翰森制药","start_time":0,"source_url":"","article_id":"1161478088","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1161478088","pubTimestamp":1790156683,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hansoh Pharmaceutical Group Company Limited (Hansoh Pharma) announced on 23 September 2026 that its Interim Report 2026 is now available in both English and Chinese on the company’s website...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03692":"翰森制药"},"translate_title":"豪森制药发布2026年中期报告；敦促股东使用数字访问，可应要求免费打印副本","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03692":1},"content_text":"Hansoh Pharmaceutical Group Company Limited (Hansoh Pharma) announced on 23 September 2026 that its Interim Report 2026 is now available in both English and Chinese on the company’s website (www.hspharm.com) and on the Hong Kong Stock Exchange’s HKEXnews portal (www.hkexnews.hk).\nThe board encourages shareholders and the investing public to review the online version to expedite access and support paper-saving efforts. Non-registered shareholders who cannot receive email notifications or access the web version may request a free printed copy. To obtain hard-copy materials, they must complete the enclosed request form and return it to the company’s Hong Kong branch share registrar, Tricor Investor Services Limited, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, using the prepaid mailing label, or email the registrar at 3692-ecom@vistra.com.\nShareholders holding shares through banks, brokers, custodians, nominees or HKSCC Nominees Limited are advised to provide a functional email address to their intermediaries to receive future electronic notices and actionable corporate communications. Until a valid email address is lodged with Tricor, such investors will receive printed notices and documents only.\nEnquiries can be directed to Tricor’s hotline on +852 2980 1333 between 9:00 a.m. and 6:00 p.m., Monday to Friday (excluding public holidays), or via the above email. The notification letter is signed by Chairlady Zhong Huijuan on behalf of Hansoh Pharma.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1161478088","isCrawlerRequest":true}